Clinical trial · Interventional
Dynamic Infrared Thermography in Breast Cancer Diagnostics
Dynamic Infrared Thermography in Breast Cancer Diagnostics. A Diagnostic Accuracy Study Comparing Dynamic Infrared Thermography Against Mammography (Reference Standard)
NCT02829021CI-TRIAL-00022957completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study evaluate diagnostic accuracy of dynamic infrared thermography compared to mammography (reference test) in breast cancer diagnostics. Women aged 50-70 years, selected for assessment after mammography screening were invited to dynamic infrared thermography before clinical mammography and further examination.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| FLIR ThermaCAM P-65 | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- Thermography and mammography
- description
- All participants will be examined with 1. Dynamic infrared thermography (FLIR ThermaCAM P-65) 2. Mammography, clinical examination and if necessary breast tissue biopsy to diagnose breast cancer.
- interventionNames
- Device: FLIR ThermaCAM P-65
Primary outcomes (1)
- measure
- Diagnostic accuracy of Thermography compared with Mammography and breast biopsy.
- timeFrame
- Baseline
- description
- Can thermography distinguish benign from malign tumours in breast cancer diagnostics. The gold standard is breast biopsy pathology. The outcome is measured as number of subjects with pathological diagnosis of cancer.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 50 Years
- Maximum age
- 69 Years
Show eligibility criteria text
Inclusion Criteria: * women, * aged 50-69 * attending the Norwegian Breast Screening Program, * recalled for assessment after positive mammography screening Exclusion Criteria: * not attending the Norwegian Breast Screening Program, * recalled to mammography for other reason than positive screening mammogram.
References
Publications (0)
Data not yet available
No reference posted for this study.